6 - Terapia Trimodale Nel Trattamento Conservativo Della Neoplasia Vescicale

Abstract

Get full access to this article

View all access options for this article.

References

Chang

Bochner

Chou

et al . Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary. J Oncol Pract 2017;13(9):621-5.

Walker

Doiron

French

et al . Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers. Clin Oncol 2017; 29 818-26.

Jereczek-Fossa

Colombo

Magnani

et al . Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy. Tumori 2015;101(2):174-8.

Arcangeli

Strigari

A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC). Crit Rev Oncol Hematol 2015;94(1):105-15.

Giacalone

Shipley

Clayman

et al . Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol 2017; 71(6):952-60.

Weiss

Wittlinger

Engehausen

et al . Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy. Int J Radiat Oncol Biol Phys 2008;70:1502-6.

Zietman

Grocela

Zehr

et al . Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 2001;58:380-5.

Rodel

Grabenbauer

Kuhn

et al . Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 2002; 20: 3061-71.

Ramani

Maddineni

Grey

Clarke

NW.

Differential complication rates following radical cystectomy in the irradiated and non-irradiated pelvis. Eur Urol 2010; 57: 1058-63.

10.

Bouchner

Figueroa

Skinner

et al . Salvage radical cistoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol 1998; 160:29-33.

11.

Zietman

Sacco

Skowronski

et al . Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors. J Urol 2003; 170:1772-6.

12.

James

Hussain

Hall

et al . Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012;366:1477-88.

13.

Arcangeli

Strigari

Arcangeli

Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials. Crit Rev Oncol Hematol 2015;95(3):387-96.

14.

Rose

Deal

Ladoire

et al . Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer. Bladder Cancer 2016;2(4):405-13.

15.

Vashistha

Wang

Mazzone

et al . Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys 2017;97(5):1002-20.

16.

Caffo

Thompson

De Santis

et al . Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. Radiother Oncol 2016;121(2):193-8.

17.

Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005. 48: 202-5.

18.

Kragelj

Zaletel-Kragelj

Sedmak

Cufer

Cervek

Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer. Radiother Oncol 2005;75:44-7.

19.

Advanced Bladder Cancer Overview Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer. Chichester, UK: John Wiley & Sons, Ltd.; 2008 (Cochrane Library; Issue 2), 〈Available at http://www.uptdate-software.com〉.

20.

Shipley

Kaufman

Zehr

et al . Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002; 60:62-7.

21.

Kachnic

Kaufman

Heney

et al . Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 1997;15:1022-9.

22.

Ploussard

Daneshmand

Efstathiou

et al . Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol 2014;66(1):120-37.

23.

Gakis

Efstathiou

Lerner

et al . ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2013;63:45-57.